Wednesday, February 9, 2022

February 08, 2022 at 04:46PM AFSTYLA

AFSTYLA, Antihemophilic Factor (Recombinant), Single Chain, is a recombinant, antihemophilic factor indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for:
• On-demand treatment and control of bleeding episodes,
• Routine prophylaxis to reduce the frequency of bleeding episodes,
• Perioperative management of bleeding.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/d6EMp8W

No comments:

Post a Comment